Novel Immunotherapy for Cancer Takes Cue From Transplant Rejection

A novel immunotherapy treatment works by triggering genetically modified T cells to reject cancer, much as they would a transplanted organ, researchers say.
Reuters Health Information

source https://www.medscape.com/viewarticle/964898?src=rss